LOGIN
No difference with gabapentin versus placebo following rib fracture in critically ill patients
February 2019
No difference with gabapentin versus placebo following rib fracture in critically ill patients
Study Type:Randomized Trial
OE Level Evidence:2
Journal Level of Evidence:N/A
A double-blind, randomized controlled trial of gabapentin vs. placebo for acute pain management in critically ill patients with rib fractures
Injury. 2018 Sep;49(9):1693-1698. doi: 10.1016/j.injury.2018.06.002Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
40 patients with one or more rib fractures were randomized to the addition of either gabapentin 300mg or placebo three times daily to a mutlimodal analgesia protocol. Patients were primarily assessed for analgesic outcomes over the first 7 days of treatment, including pain scores and narcotic consumption. Results on these measures demonstrated no significant differences between groups on any day. ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.